INDIRA SERVIDA: Open Payments
NPI 1962911933 · DUARTE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$831 in 19 payments from 8 companies in 2025. Trend: 2023 $301 · 2024 $451 · 2025 $831
Food & beverage: $573Education: $258
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 6 | $261 |
| SOBI, INC | 3 | $198 |
| Astellas Pharma US Inc | 3 | $151 |
| GENZYME CORPORATION | 2 | $85 |
| Genentech USA, Inc. | 2 | $50 |
| Alexion Pharmaceuticals, Inc. | 1 | $36 |
| Melinta Therapeutics, LLC | 1 | $32 |
| Regeneron Healthcare Solutions, Inc. | 1 | $17 |
Products named: Vanflyta, Cresemba, WAYRILZ, Venclexta, Gamifant, Rezzayo, LIBTAYO.
Industry payments across CA — which companies pay providers there.
